These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9526566)

  • 1. A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis.
    Gilon C; Huenges M; Mathä B; Gellerman G; Hornik V; Afargan M; Amitay O; Ziv O; Feller E; Gamliel A; Shohat D; Wanger M; Arad O; Kessler H
    J Med Chem; 1998 Mar; 41(6):919-29. PubMed ID: 9526566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond.
    Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G
    Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent cyclic disulfide antagonists of somatostatin.
    Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
    Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
    J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units.
    Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C
    J Med Chem; 2002 Apr; 45(8):1665-71. PubMed ID: 11931620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.
    Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M
    J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin potentiates supramaximal caerulein-stimulated pancreatic amylase secretion via its action on somatostatin secretion.
    Barreto SG; Carati CJ; Schloithe AC; Toouli J; Saccone GT
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1268-73. PubMed ID: 19779018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational mimicry: synthesis and solution conformation of a cyclic somatostatin hexapeptide containing a tetrazole cis amide bond surrogate.
    Beusen DD; Zabrocki J; Slomczynska U; Head RD; Kao JL; Marshall GR
    Biopolymers; 1995 Aug; 36(2):181-200. PubMed ID: 7492745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
    Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
    J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
    Rivier JE; Kirby DA; Erchegyi J; Waser B; Eltschinger V; Cescato R; Reubi JC
    J Med Chem; 2005 Jan; 48(2):515-22. PubMed ID: 15658865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
    Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
    J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements.
    De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G
    Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
    Lewis I; Bauer W; Albert R; Chandramouli N; Pless J; Weckbecker G; Bruns C
    J Med Chem; 2003 Jun; 46(12):2334-44. PubMed ID: 12773038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A light-activated beta-turn scaffold within a somatostatin analog: NMR structure and biological activity.
    Ulysse LG; Chmielewski J
    Chem Biol Drug Des; 2006 Feb; 67(2):127-36. PubMed ID: 16492160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
    Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
    J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells.
    Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M
    J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution.
    Gairí M; Saiz P; Madurga S; Roig X; Erchegyi J; Koerber SC; Reubi JC; Rivier JE; Giralt E
    J Pept Sci; 2006 Feb; 12(2):82-91. PubMed ID: 16365912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.